Related Experiment Video
Updated: Mar 3, 2026
03:53
Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
Published on: December 29, 2023
1.3K
Membrane phospholipids in the regulation of tissue factor procoagulant function
Shabbir A Ansari1, Mohini Mendiratta2, Atrayee Bhattacharya1
1Department of Cellular and Molecular Biology, The University of Texas at Tyler School of Medicine, The University of Texas at Tyler Health Science Center, Tyler, Texas, USA.
Current Opinion in Hematology
|March 2, 2026
Summary
Membrane lipid remodeling is key to tissue factor (TF) activity, shifting TF from an inactive to an active state. Understanding this phospholipid-dependent decryption is vital for new antithrombotic strategies.
Area of Science:
- Biochemistry
- Cell Biology
- Hemostasis
Background:
- Tissue Factor (TF) traditionally viewed as primarily regulated by protein interactions.
- Emerging evidence highlights the critical role of membrane lipid environment in modulating TF activity.
Purpose of the Study:
- To synthesize current understanding of TF regulation, emphasizing membrane lipid remodeling.
- To update mechanistic models of TF procoagulant function based on recent biophysical and functional studies.
Main Methods:
- Review of biophysical, mechanistic, and functional studies on TF-lipid interactions.
- Analysis of high-resolution imaging and molecular dynamics simulations.
- Integration of data on phospholipid remodeling and its impact on TF activity.
Main Results:
- TF exists in a low-activity, encrypted state, requiring membrane reorganization for activation.
- Phospholipid remodeling, including phosphatidylserine externalization and sphingomyelin hydrolysis, drives TF decryption.
- Lipid modulation alters protein-lipid interactions, membrane curvature, and microdomains, optimizing clotting factor alignment.
Conclusions:
- Membrane phospholipids are active regulators of TF function in both normal and disease states.
- Defining phospholipid-dependent TF decryption pathways is crucial for future coagulation research.
- Targeting membrane-driven TF activity offers potential for novel antithrombotic therapies.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
14.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.2K
01:16Clot Retraction and Fibrinolysis
9.7K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.7K
01:09Coagulation
11.3K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.3K
01:42Phosphoinositides and PIPs
10.4K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.4K
01:35Asymmetric Lipid Bilayer
10.5K
Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
10.5K